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The data presented in this article are related to the research article
entitled “Probing the dynamics of complexed local anesthetics via
neutron scattering spectroscopy and DFT calculations (http://dx.
doi.org/10.1016/j.ijpharm.2017.03.051)” (Martins et al., 2017) [1].
This work shows the molecular and structural behavior of the local
anesthetics (LAs) bupivacaine (BVC, C18H28N2O) and ropivacainevier Inc. This is an open access article under the CC BY license
/j.ijpharm.2017.03.051
Martins).
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M.L. Martins et al. / Data in Brief 15 (2017) 25–2926(RVC, C17H26N2O) before and after complexation with the water-
soluble oligosaccharide 2-hydroxypropyl−β−cyclodextrin (HP-β-
CD).
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Physics, chemistry and pharmaceuticsore speciﬁc sub-
ject areaMolecular vibration on complexed local anestheticsype of data Figures and table
ow data was
acquiredThe Raman spectroscopy (RS) data were obtained on a MultiRAM FT spectro-
meter, Bruker, equipped with a Nd:YAG laser. The Fourier transformed infrared
spectroscopy (FTIR) data was acquired on an ATR Crystal spectrometer, Bruker.
The X-ray diffraction (XRD) data was collected on a D8 – Discover dif-
fractometer, Bruker.ata format Raw and analysed data
xperimental
factorsPowder samplesxperimental
featuresRS was collected between 200 and 3500 cm-1 with an incident wavelength of
1064 nm and a laser powers of 250 mW. FTIR data were collected between 400
and 4000 cm-1 with 500 scans for each sample. XRD data was collected with a
Cu radiation source.ata source
locationCopenhagen, Denmark.ata accessibility Data are available in this article.
elated research
articleProbing the dynamics of complexed local anesthetics via neutron scattering
spectroscopy and DFT calculationsValue of the data
 Relevant data on the characterization of local anesthetics RVC and BVC and the respective
complexes.
 Data to be used on understanding molecular changes on local anesthetics after complexation in
HP-β-CD.
 RS, FTIR and XRD data to be used as complementary information to several characterization
techniques on pharmaceutical research.1. Data
FTIR and Raman spectra for BVC, RVC and HP-β-CD are presented in Fig. 1 (a) and (b) to be used as complemmentary data
for the neutron scattering analysis presented on reference [1]. Table 1 presents the modes assignment, based on references [2–
4]. Fig. 2(a) presents FTIR data for BVC and RVC BVC after complexation with HP-β-CD, thus BVC-HP-β-CD and RVC-HP-β-CD.
Fig. 2(b) shows the respective RS spectra. In Fig. 3, X-ray diffraction data is presented for BVC-HP-β-CD and RVC-HP-β-CD, i.e.
RVC after complexation with HP-β-CD.
Table 1
Modes assignment for FTIR and RS for BVC, RVC and HP-β-CD.
Sample Frequencies (cm-1) Modes Assignment
BVC and
RVC
 3509 (BVC)
 3512 (RVC)
O-H bond stretching
 3240 and 3318 (BVC)
 3199, 3278 and 3326 (RVC)
Stretching of hydrogen-bonded N-H group of the
mono-substituted amides, O¼C-N-H
2960 CH3 stretching
2500 - 2700 Stretching of N-H-Cl
1700 - 1600 C¼C and C¼O stretching
1680 – 1630 Amide carbonyl stretching band (�(C¼O))
1550 Amide II vibration (C-N stretching vibrations toge-
ther with N-H bending)
1250 C-N-H stretch vibrations
1470 - 1250 Information on the rings and the methyl (CH3) and
methylene (CH2) groups
1466, 1436 and 1471 CH2-bending
 1371 (BVC)
 1399 (RVC)
CH3 bending
1000 – 600 Bending of C-H groups located either in the rings or
in the carbon groups
Around 780 Adjacent CH wag modes
HP-β-CD 3332 O-H bond vibration
2928 C-H out of phase stretching
1450 and 1328 C-H bending
1153, 1079 and 1014 C-O stretching
vibrations below 1000 Different types of bending of C-H bonds in the
aromatic ring.
Fig. 1. (a) FTIR and (b) Raman spectra of RVC, BVC and HP-β-CD. All data were collected at room temperature.
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2.1. Materials
BVC hydrochloride monohydrate in the form of racemate (BVC.HCl, C18H28N2O.HCl.H2O) and RVC
hydrochloride monohydrate (RVC.HCl, C17H26N2O·HCl·H2O) were donated by Cristália Prod. Quím.
Farm. Ltda (Itapira, SP, Brazil). 2-hydroxypropyl−β−cyclodextrin, HP-β-CD, (Kleptose HP®) was
obtained from Roquette Serv. Tech. Lab. (Lestrem, Cedex, France). Deionized water (Elga Maxima
System, Elga, High Wycombe, UK) was used throughout the experiments. All other reagents were of
analytical grade.
Fig. 2. FTIR(a) and RS(b) data for RVC and BVC after complexation with HP-β-CD, thus RVC-HP-β-CD and BVC-HP-β-CD.
Fig. 3. X-ray diffraction data for BVC after complexation with HP-β-CD (BVC-HP-β-CD) and for RVC after complexation with HP-
β-CD (RVC-HP-β-CD). The data were collected with Cu radiation (λ ¼ 1.54 Å). A baseline was subtracted from the data for
background correction and BVC-HP-β-CD data was shifted for better visualization.
M.L. Martins et al. / Data in Brief 15 (2017) 25–29282.2. Sample preparation
Samples were prepared as described in [5]. Inclusion complexes were prepared by stirring equi-
molar amounts of the local anesthetics (racemate BVC.HCl and RVC.HCl) and HP-β-CD (1:1 M ratio) in
deionized water at room temperature (25 7 1) ◦C for 24 h. After completely dissolution and reaching
equilibrium (4 h), the solution was freeze-dried (Labconco-freeze dry system/Freezone® 4.5) and
stored at -20 ◦C until further use.2.3. Fourier Transformed Infrared Spectroscopy (FTIR)
FTIR spectra were collected to all samples at room temperature between 400 and 4000 cm-1, using
an ATR Crystal from Bruker. For each sample 500 scans were carried out. A background measurement
was collected at the beginning of the experiment, and the obtained signal was subsequently sub-
tracted from all the other measurements.2.4. Raman Scattering (RS)
RS between 200 and 3500 cm-1 were collected at room temperature using a MultiRAM FT-Raman
spectrometer from Bruker equipped with a Nd:YAG laser. An incident wavelength of 1064 nm was
used to measure the powder samples that were carefully mounted inside of glass vials. The powder
samples were put in small glasses and a laser power of 250 mW was used to measure the HP-β-CD
and the LA samples. Due to the lower density of the complex BVC-HP-β-CD, very thin pellets were
made with the encapsulated drugs powders and a laser power of 500 mWwas used. The data analysis
was only qualitative in this experiment.
M.L. Martins et al. / Data in Brief 15 (2017) 25–29 292.5. X-ray diffraction
BVC and RVC after complexation with HP-�-CD were investigated by X-ray powder diffraction
(XPD) in a Brucker – D8 Discover diffractometer (Cu radiation – λ ¼ 1.54 Å). The experiments were
conduct with a 0.01° step, between 10° and 55°. A baseline was subtracted from the data for back-
ground correction and BVC-HP-β-CD data was shifted for better visualization.Acknowledgements
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